Description
It is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It use in the treatment of HIV infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate (TAF). Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate (TDF), TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent.
| Strength | Not specified |
| Pack Size | Not specified |
| Brand | Not specified |
| Packaging Type | Not specified |
| Composition | Not specified |
| Form | Not specified |
| Shelf Life | Not specified |
| Usages | Not specified |
| Country of Origin | Not specified |
Reviews
There are no reviews yet.